LITS
Lite Strategy, Inc. · Healthcare
Insiders bought $98K of Lite Strategy, Inc. in the last 12 months
1 insider bought on 1 day.
$98KBought, 12 mo
$946KSold, 12 mo
$38.6MMarket cap
LITS over the last year
Largest buyers, last 12 months
LITS after insider buys
3 months after each buy, from the first price a copier could get.
1 buy has 3 months of prices so far. A record shows here at 3.
Every filing
2 insider filings since 2025, newest first
About Lite Strategy, Inc.
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. It is also involved in holding Litecoin tokens as a primary reserve asset. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.